Literature DB >> 21540989

Role of post-translational modifications of HTLV-1 Tax in NF-κB activation.

Noula Shembade1, Edward W Harhaj.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1), the first human retrovirus discovered, is the etiological agent of adult-T-cell leukemia/lymphoma. The HTLV-1 encoded Tax protein is a potent oncoprotein that deregulates gene expression by constitutively activating nuclear factor-κB (NF-κB). Tax activation of NF-κB is critical for the immortalization and survival of HTLV-1-infected T cells. In this review, we summarize the present knowledge on mechanisms underlying Tax-mediated NF-κB activation, with an emphasis on post-translational modifications of Tax.

Entities:  

Keywords:  Adult-T-cell leukemia/lymphoma; Human T-cell leukemia virus type 1; Human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis; IKK; Nuclear factor-κB

Year:  2010        PMID: 21540989      PMCID: PMC3083931          DOI: 10.4331/wjbc.v1.i1.13

Source DB:  PubMed          Journal:  World J Biol Chem        ISSN: 1949-8454


  96 in total

1.  Enhanced activation of tax-dependent transcription of human T-cell leukemia virus type I (HTLV-I) long terminal repeat by TORC3.

Authors:  Hiroshi Koga; Takayuki Ohshima; Kunitada Shimotohno
Journal:  J Biol Chem       Date:  2004-10-04       Impact factor: 5.157

Review 2.  Activation of NF-kappaB by HTLV-I and implications for cell transformation.

Authors:  Shao-Cong Sun; Shoji Yamaoka
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

Review 3.  Human T cell lymphotropic virus type I genomic expression and impact on intracellular signaling pathways during neurodegenerative disease and leukemia.

Authors:  J Yao; B Wigdahl
Journal:  Front Biosci       Date:  2000-01-01

4.  Ablation of transplanted HTLV-I tax-transformed tumors in mice by antisense inhibition of NF-kappa B.

Authors:  I Kitajima; T Shinohara; J Bilakovics; D A Brown; X Xu; M Nerenberg
Journal:  Science       Date:  1993-03-12       Impact factor: 47.728

5.  CREB-2, a cellular CRE-dependent transcription repressor, functions in association with Tax as an activator of the human T-cell leukemia virus type 1 promoter.

Authors:  F Gachon; A Peleraux; S Thebault; J Dick; I Lemasson; C Devaux; J M Mesnard
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  Preferential selection of human T-cell leukemia virus type I provirus integration sites in leukemic versus carrier states.

Authors:  Keitarou Doi; Xiaolin Wu; Yuko Taniguchi; Jun-ichirou Yasunaga; Yorifumi Satou; Akihiko Okayama; Kisato Nosaka; Masao Matsuoka
Journal:  Blood       Date:  2005-04-19       Impact factor: 22.113

Review 7.  HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches.

Authors:  John M Taylor; Christophe Nicot
Journal:  Apoptosis       Date:  2008-06       Impact factor: 4.677

Review 8.  The current status of therapy for adult T-cell leukaemia-lymphoma in Japan.

Authors:  Yasuaki Yamada; Masao Tomonaga
Journal:  Leuk Lymphoma       Date:  2003-04

Review 9.  Transgenic mouse models for HTLV-I infection.

Authors:  W J Grossman; L Ratner
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996

10.  Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.

Authors:  Brian J Zarnegar; Yaya Wang; Douglas J Mahoney; Paul W Dempsey; Herman H Cheung; Jeannie He; Travis Shiba; Xiaolu Yang; Wen-Chen Yeh; Tak W Mak; Robert G Korneluk; Genhong Cheng
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

View more
  12 in total

Review 1.  Role of Exosomes in Human Retroviral Mediated Disorders.

Authors:  Monique Anderson; Fatah Kashanchi; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2018-04-14       Impact factor: 4.147

Review 2.  Human T-lymphotropic virus proteins and post-translational modification pathways.

Authors:  Carlo Bidoia
Journal:  World J Virol       Date:  2012-08-12

Review 3.  Exosomes in Viral Disease.

Authors:  Monique R Anderson; Fatah Kashanchi; Steven Jacobson
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

4.  Influence of human T-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis C virus infection.

Authors:  Mayumi Tokunaga; Hirofumi Uto; Kohei Oda; Masahito Tokunaga; Seiichi Mawatari; Kotaro Kumagai; Kouichi Haraguchi; Makoto Oketani; Akio Ido; Nobuhito Ohnou; Atae Utsunomiya; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2014-01-25       Impact factor: 7.527

5.  Is there a role for ubiquitin or SUMO in human T-cell leukemia virus type 2 Tax-induced NF-κB activation?

Authors:  Alfonso Lavorgna; Edward W Harhaj
Journal:  Future Virol       Date:  2013-03       Impact factor: 1.831

6.  Human T cell leukemia virus type 2 tax-mediated NF-κB activation involves a mechanism independent of Tax conjugation to ubiquitin and SUMO.

Authors:  Chloé Journo; Amandine Bonnet; Arnaud Favre-Bonvin; Jocelyn Turpin; Jennifer Vinera; Emilie Côté; Sébastien Alain Chevalier; Youmna Kfoury; Ali Bazarbachi; Claudine Pique; Renaud Mahieux
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

Review 7.  Regulation of the nucleocytoplasmic trafficking of viral and cellular proteins by ubiquitin and small ubiquitin-related modifiers.

Authors:  Yao E Wang; Olivier Pernet; Benhur Lee
Journal:  Biol Cell       Date:  2011-12-28       Impact factor: 4.458

8.  HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathways.

Authors:  Robert Currer; Rachel Van Duyne; Elizabeth Jaworski; Irene Guendel; Gavin Sampey; Ravi Das; Aarthi Narayanan; Fatah Kashanchi
Journal:  Front Microbiol       Date:  2012-11-30       Impact factor: 5.640

9.  Complex role of microRNAs in HTLV-1 infections.

Authors:  Gavin C Sampey; Rachel Van Duyne; Robert Currer; Ravi Das; Aarthi Narayanan; Fatah Kashanchi
Journal:  Front Genet       Date:  2012-12-17       Impact factor: 4.599

10.  Molecular characterization of HTLV-1 gp46 glycoprotein from health carriers and HAM/TSP infected individuals.

Authors:  Aline C A Mota-Miranda; Fernanda K Barreto; Maria F C Amarante; Everton Batista; Joana P Monteiro-Cunha; Lourdes Farre; Bernardo Galvão-Castro; Luiz C J Alcantara
Journal:  Virol J       Date:  2013-03-06       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.